Brie Carter

OS Therapies (NYSE:OSTX) announced on Tuesday, March 31, 2026, that it has reached a pivotal regulatory milestone by submitting its Phase 2b clinical and biomarker data to the U.S. Food and Drug Administration (FDA) for a formal Pre-BLA (Biologics License Application) meeting.

SCYNEXIS (NASDAQ:SCYX) announced a transformative strategic shift on Tuesday, March 31, 2026, transitioning its core focus toward rare kidney diseases through a significant asset acquisition and a major equity financing.

Soligenix (NASDAQ:SNGX) reported financial results for the full year ended December 31, 2025, on March 31, 2026, emphasizing a clear pathway toward critical late-stage clinical data readouts.

McCormick & Company (NYSE:MKC) announced robust first-quarter fiscal 2026 results on Tuesday, characterized by a significant double-digit increase in net sales following the successful integration of its major regional acquisition.

Sound Group (NASDAQ:SOGP) reported a significant financial turnaround for the fiscal year ended December 31, 2025, characterized by robust revenue growth and a return to bottom-line profitability.

Organigram Global (NASDAQ:OGI) announced today that its shareholders have granted overwhelming approval for the acquisition of Germany’s Sanity Group.

The European Central Bank has begun accepting tokenised securities issued on distributed ledger technology as collateral for Eurosystem credit operations, marking a significant step for on-chain finance.

The National Football League has asked prediction market platforms including Kalshi and Polymarket to restrict contracts tied to events that could be easily manipulated.

Asset manager Grayscale said Zcash could see significant upside if rising AI-driven surveillance increases demand for financial privacy.

Bitcoin’s hashrate has declined around 4% year-to-date, marking its first first-quarter drop in six years as mining economics weaken.